Treatment and reassurance at JGH clinic for patients with rare blood cancers
A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.
Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.